Search Results - "DiNofia AM"

Single-Cell Transcriptomic Analysis of Myeloid Lineage Evolution from CD19 CAR-T Cell Therapy.

Authors: Cui, Yajuan Wang, Peilong Zhu, Hongkai et al.

Source: Pathobiology. 2025, Vol. 92 Issue 3, p180-186. 7p.

CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy.

Authors: Myers RM DiNofia AM Li Y et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Apr 17; Vol. 13 (4). Date of Electronic Publication: 2025 Apr 17.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Regulatory challenges of personalized medicine in the real world: are the right patients being treated with CD19-targeting CAR T-cells?

Authors: Sebe A Hernani R Müller-Berghaus J

Source: EMBO molecular medicine [EMBO Mol Med] 2026 Jun; Vol. 18 (6), pp. 2007-2011. Date of Electronic Publication: 2026 Apr 27.

Publication Type: Journal Article; Review

Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE

Role of procalcitonin, C-reactive protein and ferritin in cytokine release syndrome after CAR T-cell therapy in children and young adults.

Authors: M, Caballero-Bellón S, Bobillo-Perez A, Català et al.

Source: Biomarkers. Mar2025, Vol. 30 Issue 2, p115-122. 8p.

In vivo CAR-T therapy: from molecular design to precision delivery.

Authors: Li H Wen W Zhao X et al.

Source: Journal of nanobiotechnology [J Nanobiotechnology] 2026 Apr 02; Vol. 24 (1). Date of Electronic Publication: 2026 Apr 02.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155 (Electronic) Linking ISSN: 14773155 NLM ISO Abbreviation: J Nanobiotechnology Subsets: MEDLINE

Targeting triple-negative breast cancer using cord-blood CD34⁺ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activity.

Authors: Li, Yan-Ruide Shen, Xinyuan Zhu, Yichen et al.

Source: Journal of Hematology & Oncology. 10/13/2025, Vol. 18 Issue 1, p1-29. 29p.

LSD1 调控肿瘤免疫机制的研究进展.

Alternate Title: Research progress of LSD1 in regulating tumor immune mechanisms.

Authors: 龙丽娟 宋松泽 叶棋浓 et al.

Source: Basic & Clinical Medicine. Aug2025, Vol. 45 Issue 8, p1088-1092. 5p.

Unraveling resistance mechanisms in anti-CD19 chimeric antigen receptor-T therapy for B-ALL: a novel in vitro model and insights into target antigen dynamics.

Authors: Li, Hongzhe Wang, Yuwen Liu, Rongrong et al.

Source: Journal of Translational Medicine. 5/21/2024, Vol. 22 Issue 1, p1-15. 15p.

Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy.

Authors: Li, Wenjie Ding, Lixia Shi, Wenhua et al.

Source: Journal of Translational Medicine. 3/22/2023, Vol. 21 Issue 1, p1-11. 11p.

Exploring CAR cell therapies beyond CAR-T for myeloid malignancies.

Authors: Li YR Chen Y Yang L

Source: Journal of biomedical science [J Biomed Sci] 2026 Jun 04; Vol. 33 (1). Date of Electronic Publication: 2026 Jun 04.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 9421567 Publication Model: Electronic Cited Medium: Internet ISSN: 1423-0127 (Electronic) Linking ISSN: 10217770 NLM ISO Abbreviation: J Biomed Sci Subsets: MEDLINE

Synergizing hypomethylating agents with off-the-shelf CD70-targeted chimeric antigen receptor-engineered natural killer T cells for the treatment of acute myeloid leukemia.

Authors: Li YR Shen X Chen Y et al.

Source: Leukemia [Leukemia] 2026 May; Vol. 40 (5), pp. 880-893. Date of Electronic Publication: 2026 Mar 26.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Recent advances and challenges of cellular immunotherapies in lung cancer treatment.

Authors: Yang, Chengfei Liu, Yue Huang, Ziqi et al.

Source: Experimental Hematology & Oncology. 7/7/2025, Vol. 14 Issue 1, p1-27. 27p.

Next-generation immunotherapeutic approaches for blood cancers: Exploring the efficacy of CAR-T and cancer vaccines.

Authors: Hushmandi, Kiavash Imani Fooladi, Abbas Ali Reiter, Russel J. et al.

Source: Experimental Hematology & Oncology. 5/17/2025, Vol. 14 Issue 1, p1-47. 47p.

Oncofertility in pediatric patients: current perspectives.

Authors: Marques, Rafael João Oura, Maria Dionísio, Rita et al.

Source: Contemporary Oncology / Współczesna Onkologia. 2022, Vol. 26 Issue 3, p165-173. 9p.

Lenalidomide overcomes the resistance to third-generation CD19-CAR-T cell therapy in preclinical models of diffuse large B-cell lymphoma.

Authors: Jin, Zhen Xiang, Rufang Qing, Kai et al.

Source: Cellular Oncology (2211-3428). Aug2023, Vol. 46 Issue 4, p1143-1157. 15p.

Strategies to overcome tumour relapse caused by antigen escape after CAR T therapy.

Authors: Lu, Yufei Zhao, Fu

Source: Molecular Cancer. 4/28/2025, Vol. 24 Issue 1, p1-17. 17p.

Emerging advances in nano-biomaterial assisted amyloid beta chimeric antigen receptor macrophages (CAR-M) therapy: reducing plaque burden in Alzheimer's disease.

Authors: Kushwaha, Nishabh Panjwani, Drishti Patel, Shruti et al.

Source: Journal of Drug Targeting. Feb2025, Vol. 33 Issue 2, p185-205. 21p.

New insights into CAR T-cell hematological toxicities: manifestations, mechanisms, and effective management strategies.

Authors: Yang, Yuanyuan Peng, Hongwei Wang, Jianxiang et al.

Source: Experimental Hematology & Oncology. 11/9/2024, Vol. 13 Issue 1, p1-18. 18p.

Recent updates on allogeneic CAR-T cells in hematological malignancies.

Authors: Mansoori, Shafieeh Noei, Ahmad Maali, Amirhosein et al.

Source: Cancer Cell International. 9/3/2024, Vol. 24 Issue 1, p1-22. 22p.

Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy.

Authors: Hughes, Andrew D. Teachey, David T. Diorio, Caroline

Source: Seminars in Immunopathology. Aug2024, Vol. 46 Issue 3/4, p1-19. 19p.